Azaftig stimulates in vitro lipolysis by rodent and human adipocytes

Department of Medicine, Louisiana State University Health Sciences Center New Orleans, New Orleans, Louisiana, United States
Biochemical and Biophysical Research Communications (Impact Factor: 2.3). 06/2002; 293(2):847-9. DOI: 10.1016/S0006-291X(02)00300-5
Source: PubMed


Azaftig is an urinary proteoglycan present in some cancer and AIDS patients experiencing weight loss. Administration of azaftig to mice results in weight loss that is associated with loss of fat depot. So far, very little is known about the mechanism underlying loss of fat depot in mice or weight loss in patients excreting azaftig. Augmentation of lipolysis may be one mechanism that can cause reduction of fat depot. Therefore, the present study was designed to examine the effect of azaftig on lipolysis by adipocytes derived from obese rats and humans. Results show a dose-dependent potentiation of lipolysis by azaftig in both rat and human adipocytes.

Download full-text


Available from: Chandan Prasad, Aug 30, 2014
16 Reads
  • [Show abstract] [Hide abstract]
    ABSTRACT: Substantial weight loss in individuals with AIDS or cancer is associated with a poor prognosis and increased mortality. We have isolated and partially characterized a proteoglycan (named azaftig) from the urine of a cancer patient experiencing weight loss. Furthermore, we have raised a polyclonal antibody to azaftig in rabbits and developed a procedure to measure the level of this proteoglycan in urine by Western blot. We report the presence of azaftig in the urine of cancer and AIDS patients experiencing weight loss, but not in the control or weight-stable subjects. The azaftig-like immunoreactivity was present in 69.2% (9/13) of patients with weight loss, but only in 27.0% (3/11) of weight-stable cancer or AIDS patients and none of the control subjects (n = 8).
    Biochemical and Biophysical Research Communications 02/1999; 254(3):642-6. DOI:10.1006/bbrc.1998.9985 · 2.30 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Cachexia is a complex medical condition characterized by significant weight loss associated with decreased body fat and protein; the condition may present itself with or without anorexia. We have isolated and partially characterized a proteoglycan (azaftig) from the urine of cancer and AIDS patients experiencing weight loss. When given to mice, the purified azaftig resulted in a significant decrease in body weight and body fat without any effect on appetite. The results of these studies show that azaftig may be one of the many factors participating in the emergence of the cachectic state.
    Life Sciences 02/1999; 64(15):1339-47. DOI:10.1016/S0024-3205(99)00069-7 · 2.70 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Phospholipase C (α toxin of Clostridium perfringens) has been found to cause, at relative high concentrations, the lysis of fat cells isolated from rat epididymal adipose tissue. Lysis of the fat cells resulted in the loss of insulin response in proportion to the amount of cells broken. It is suggested that the effects of insulin on glucose metabolism by the fat cell are dependent on the presence of an intact cell membrane. The level of flexokinase activity in the fat cell was not affected by insulin or phospholipase C; sufficient hexokinase was present to account for all the glucose phosphorylated by fat cells in response to insulin. Evidence is presented that glucose is transported in the fat cell by a carrier-mediated, stereospecific process. Insulin and treatment of fat cells with phospholipase C under conditions that did not cause lysis, stimulated the transport of glucose. Anabolic processes, such as fatty acid synthesis from glucose and amino acid incorporation into protein, were also stimulated by insulin and phospholipase C. The action of phospholipase C on glucose transport and amino acid utilization was a function of enzyme concentration, suggesting that the amount of cellular phospholipid hydrolyzed by the enzyme determined the amount of solute entering the cell. Phospholipids appear, therefore, to be linked to transport processes. The common effects of insulin and phospholipase C on the fat cell suggests that the same parameter in the cell is affected by these substances. It is hypothesized that insulin and phospholipase C act on the plasma membrane to alter the configuration of its lipoproteins from a laminated to a micellar or globular form. The latter configuration of the membrane lipoproteins might have interstices that permit the carrier-mediated passage of solutes into the cell.
    Journal of Biological Chemistry 01/1966; 241(1):130-139. DOI:10.1002/cphy.cp050147 · 4.57 Impact Factor